A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Several professionals said the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking fines, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the service has removed problematic material and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step guides for preparing or administering at residence.
After minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious medical dangers”.
